UPDATE
: Friday, December 13, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Hanmi’s Q3 sales rise 13%
Hanmi Pharmaceutical said Tuesday that it recorded sales of 265.7 billion w...
by Lee Han-soo
|
2019-10-29 16:04
라인
Allergan’s Botox reaffirms efficacy in treating chronic migraines
Allergan Korea said that it has demonstrated that Botox, its botulinum toxi...
by Lee Han-soo
|
2019-10-29 15:00
라인
JW Shinyak launches antithrombotic medication
JW Shinyak, a subsidiary of JW Holdings, said it started marketing J-retal ...
by Lee Han-soo
|
2019-10-28 18:49
라인
Macrogen wins patent for fusion genes that causes lung adenocarcinoma
Macrogen said that it has registered a patent for AXL-MBIP, a fusion gene t...
by Lee Han-soo
|
2019-10-28 17:08
라인
Hanall posts ₩28 billion in Q3 sales
HanAll Biopharma said that it recorded 28 billion won ($23.9 million) in sa...
by Lee Han-soo
|
2019-10-28 17:08
라인
'Development of new psoriasis treatments good news for patients'
Development of new psoriasis treatments is helping psoriasis patients both ...
by Lee Han-soo
|
2019-10-28 13:56
라인
Korea should import new drug to treat pulmonary arterial hypertension
Physicians have raised voice for importing new drugs to treat pulmonary art...
by Kim Yun-mi
|
2019-10-25 18:08
라인
Hanmi’s US partner resubmits BLA application for neutropenia treatment
Spectrum, Hanmi Pharmaceutical’s U.S. partner, said Friday that it has resu...
by Lee Han-soo
|
2019-10-25 17:36
라인
'Pharmacovigilance as crucial as clinical trials'
The importance of pharmacovigilance, which is the task of collecting and an...
by Lee Han-soo
|
2019-10-24 18:21
라인
Daewoong releases trial data on gastroesophageal reflux disease drug
Daewoong Pharmaceutical said that it has presented its phase 1 multiracial ...
by Lee Han-soo
|
2019-10-24 17:00
라인
Novartis’ Cosentyx strengthens position as comprehensive psoriasis treatment
Novartis said it presented the long-term real-world evidence data for Cosen...
by Lee Han-soo
|
2019-10-24 14:47
라인
AbbVie draws favorable rating for its rheumatism drug in Europe
AbbVie Korea said the European Medicines Agency's Committee for Medicin...
by Lee Han-soo
|
2019-10-24 14:45
라인
PharmAbcine sets up US unit to develop anticancer drug
PharmAbcine said it would speed up the development of a new anticancer drug...
by Jeong Sae-im
|
2019-10-23 15:48
라인
Pfizer Korea reaffirms corporate missions on 50th anniversary
Under the corporate slogan of “breakthroughs that change patients' live...
by Lee Han-soo
|
2019-10-23 14:53
라인
Gemvax & Kael's GV1001 shows efficacy as prostate cancer treatment
Gemvax & Kael said that it has confirmed the efficacy of GV1001 in treating...
by Lee Han-soo
|
2019-10-23 10:59
라인
Pfizer’s atopic drug should overcome side effects to challenge Sanofi’s Dupixent
Pfizer recently proved the efficacy of its investigational atopic dermatiti...
by Kim Yun-mi
|
2019-10-22 14:17
라인
Pharma industry hits government steps regarding ranitidine ban
The local pharmaceutical industry is expressing its distrust and displeasur...
by Lee Han-soo
|
2019-10-21 17:16
라인
Dong-A ST leaves KPBMA to ‘repent of illegal rebate’
Dong-A ST is voluntarily giving up its membership of the Korea Pharmaceutic...
by Jeong Sae-im
|
2019-10-21 16:42
라인
GSK applies for additional indication of asthma inhaler Trelegy Ellipta
GSK said that it has applied to obtain an additional indication for Trelegy...
by Lee Han-soo
|
2019-10-21 15:32
라인
Drug firms’ Q3 earnings to be fairly good
Korea’s large pharmaceutical companies are expected to have yielded good ea...
by Jeong Sae-im
|
2019-10-21 12:27
-
1
2
3
4
5
6
7
8
9
10
다음
-
GC, Add Pharma to co-develop synthetic drugs
Helixmith to clarify why gene therapy study had data error
Daewoong releases trial results for autoimmune disease treatment candidate
Medical kiosks installed at major subway stations to help foreigners
GC, Add Pharma to co-develop synthetic drugs
Helixmith to clarify why gene therapy study had data error
Daewoong releases trial results for autoimmune disease treatment candidate
Medical kiosks installed at major subway stations to help foreigners
여백
Most viewed
1
Aprogen, 1st Korean biotech firm to win unicorn status
2
Korea selected as 'Medical Tourism Destination of the Year'
3
Sanofi, Hanmi to look for new partner to commercialize efpeglenatide
4
ABL Bio unveils new bispecific antibody at US meet
5
AbbVie's releases new data for chronic lymphocytic leukemia treatment
6
Will partial success of Biogen’s Alzheimer’s drug lead to FDA approval?
7
Samsung execs get jail term for destroying evidence
8
Japan OKs Medipost's P2 trial of stem cell-serviced osteoarthritis treatment
9
Korean physician 1st Asian to do 1,000 robotic myomectomy surgeries
10
Samsung Bioepis to start P3 trial for Ontruzant in China
여백
Opinion
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
여백
Back to Top